Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Welgene Biotech Co., Ltd. specializes in high-throughput genetic testing services using advanced technologies such as DNA microarrays, next-generation sequencing (NGS), and real-time quantitative PCR. The company operates a certified laboratory with TAF ISO17025 and TFDA LDTS accreditations. Its offerings include preimplantation embryo screening, chromosomal abnormality detection via microarrays, non-invasive prenatal tests based on NGS technology, as well as bioinformatics support for clinical applications. The company primarily serves the academic research sector and healthcare providers within Taiwan's market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WellGene.